Drugs
Oseltamivir
4 articles published between May 20, 2026 and October 3, 2026.
WHAT THE STUDY ACTUALLY SAYSThe CENTERSTONE trial found a single dose lowered lab-confirmed spread to household contacts by about a third, but spread that made contacts ill was not significantly cut, and resistant virus emerged in some patients.
3 min read
WHAT THE STUDY ACTUALLY SAYSA bird-flu virus from British Columbia poultry carried the H275Y mutation that blunts Tamiflu and peramivir. In the lab it stayed vulnerable to zanamivir and baloxavir — and was less virulent in mice.
3 min read
EXPLAINERThe two most-prescribed respiratory antivirals sit at opposite ends of the evidence. One shortens flu by less than a day on average; the other cut serious outcomes sharply — but only in the group at real risk.
3 min read
WHAT THE STUDY ACTUALLY SAYSAn 8-year-old boy had brain inflammation with no respiratory symptoms. Every respiratory, blood and rectal sample tested negative; the virus was in his cerebrospinal fluid alone.
5 min read
This page indexes this newspaper’s reporting on Oseltamivir. It is not a medical reference entry, and nothing here is medical advice. See our editorial standards.